This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Helene Langevin | |
---|---|
3rdDirector of the National Center for Complementary and Integrative Health | |
Assumed office November 26, 2018 | |
Preceded by | Josephine P. Briggs |
Personal details | |
Education | McGill University |
Website | Office of the Director |
Scientific career | |
Fields | Neurological Science |
Institutions | University of Vermont College of Medicine |
Helene Langevin is Director of the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).
She was a professor in the University of Vermont College of Medicine's Department of Neurological Sciences. She is best known for characterizing certain cellular and mechanical effects of acupuncture. She was also a Professor in Residence of Medicine at Harvard Medical School,Brigham and Women's Hospital. Prior to working at NIH,Langevin was the Director of the Osher Center for Integrative Medicine,jointly owned by Brigham and Women's Hospital and Harvard Medical School.
Langevin was principal investigator of studies funded by the National Institutes of Health. [1] The Boston Globe describes her as a "celebrity" in the world of acupuncture. [2]
Langevin received an MD degree from McGill University in 1978. She did a post doctoral research fellowship in Neurochemistry at the MRC Neurochemical Pharmacology Unit in Cambridge,England,residency in Internal Medicine and fellowship in Endocrinology and Metabolism at Johns Hopkins Hospital. She was a Professor in Residence of Medicine at Harvard Medical School,Brigham and Women's Hospital. She was also a part-time Professor of Neurology,Orthopedics and Rehabilitation at the University of Vermont College of Medicine. She was the Principal Investigator of two NIH-funded studies investigating the role of connective tissue in low back pain and the mechanisms of manual and movement based therapies. [3] Her previous studies in humans and animal models have found that "needle grasp",the biomechanical component of de qi,may be caused by connective tissue winding around the needle. [2]
Helene Langevin was appointed as Director of the Osher Center for Integrative Medicine at Harvard Medical School and Brigham and Women's Hospital in November 2012. [4]
In December 2001,a study by Langevin and several other researchers at the University of Vermont College of Medicine regarding the "Biomechanical response to acupuncture needling in humans" was published by the peer-reviewed Journal of Applied Physiology ,which examined the effects of mechanical tissue stimulation during tissue stretch and during acupuncture. [5]
Acupuncture is a form of alternative medicine and a component of traditional Chinese medicine (TCM) in which thin needles are inserted into the body. Acupuncture is a pseudoscience;the theories and practices of TCM are not based on scientific knowledge,and it has been characterized as quackery.
The National Center for Complementary and Integrative Health (NCCIH) is a United States government agency which explores complementary and alternative medicine (CAM). It was initially created in 1991 as the Office of Alternative Medicine (OAM),and renamed the National Center for Complementary and Alternative Medicine (NCCAM) before receiving its current name in 2014. NCCIH is one of the 27 institutes and centers that make up the National Institutes of Health (NIH) within the United States Department of Health and Human Services.
Dry needling,also known as trigger point dry needling and intramuscular stimulation,is a treatment technique used by various healthcare practitioners,including physical therapists,physicians,and chiropractors,among others. Acupuncturists usually maintain that dry needling is adapted from acupuncture,but others consider dry needling as a variation of trigger point injections. It involves the use of either solid filiform needles or hollow-core hypodermic needles for therapy of muscle pain,including pain related to myofascial pain syndrome. Dry needling is mainly used to treat myofascial trigger points,but it is also used to target connective tissue,neural ailments,and muscular ailments. The American Physical Therapy Association defines dry needling as a technique used to treat dysfunction of skeletal muscle and connective tissue,minimize pain,and improve or regulate structural or functional damage.
Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role,she served as President of Brigham Health and its Brigham and Women's Hospital,Professor of Medicine at Harvard Medical School,and Director of the NIH's National Heart,Lung,and Blood Institute.
JoAnn Elisabeth Manson is an American physician and professor known for her pioneering research,public leadership,and advocacy in the fields of epidemiology and women's health.
Martin (Maish) L. Yarmush is an academic,American scientist,physician,and engineer known for his work in biotechnology and bioengineering. His faculty career began in 1984 at MIT in the Department of Chemical Engineering as a Principal Research Associate and Lucille P. Markey Scholar in Biomedical Science. In 1988 he joined Rutgers University,as Professor of Chemical and Biochemical Engineering and a member of the Center of Advanced Biotechnology and Medicine. In 1995,he returned to the Boston area to serve as the Helen Andrus Benedict Professor of Surgery and Bioengineering in the Harvard-MIT Division of Health Sciences and Technology,and to establish the Center for Engineering in Medicine at the Harvard Affiliated Teaching Hospitals. In 2007 he returned to Rutgers to hold the Paul and Mary Monroe Endowed Chair in Science and Engineering and serve as Distinguished Professor in the Department of Biomedical Engineering. He also holds a Lecturer in Surgery and Bioengineering position at Harvard Medical School,and is a member of the Senior Scientific Staff at the Shriners children's hospital in Boston.
Matthew H. Liang is a physician specializing in general internal medicine and rheumatology,Professor of Medicine at Harvard Medical School,Professor of Health Policy and Management at Harvard School of Public Health,and the Director Emeritus of Special Projects of the Robert B. Brigham Arthritis and Musculoskeletal Diseases Clinical Research Center which he founded. He is a founding faculty of the Division of General Internal Medicine and Primary Care at the Brigham and Women's Hospital and a founding faculty of the Clinical Effectiveness Program at the Harvard School of Public Health and is a Study Director in the Veterans Administration Cooperative Studies Program.
Fu's Subcutaneous Needle (FSN),invented by Dr. Zhonghua Fu in 1996,is a method for the treatment of myofascial pain and trigger points related to Traditional Chinese Medicine (TCM) and invented by Dr. D. Simons and Dr. Janet G. Travell.
Sat Bir Singh Khalsa is a researcher in the field of body mind medicine,specializing in yoga therapy. Originally from Toronto,he earned his Ph.D. at the University of Toronto,where he also began his practice of Kundalini Yoga under the tutelage of Yogi Bhajan. He is an Associate Professor of Medicine at Harvard Medical School Sat Bir Singh Khalsa serves as the Director of Yoga Research for Yoga Alliance and the Kundalini Research Institute,Research Associate at the Benson Henry Institute for Mind Body Medicine,and Research Affiliate of the Osher Center for Integrative Medicine.
Bruce Rosen is an American physicist and radiologist and a leading expert in the area of functional neuroimaging. His research for the past 30 years has focused on the development and application of physiological and functional nuclear magnetic resonance techniques,as well as new approaches to combine functional magnetic resonance imaging (fMRI) data with information from other modalities such as positron emission tomography (PET),magnetoencephalography (MEG) and noninvasive optical imaging. The techniques his group has developed to measure physiological and metabolic changes associated with brain activation and cerebrovascular insult are used by research centers and hospitals throughout the world.
Brian M. Berman is a tenured professor of family medicine at the University of Maryland School of Medicine.
Ferenc Andras Jolesz was a Hungarian-American physician and scientist best known for his research on image guided therapy,the process by which information derived from diagnostic imaging is used to improve the localization and targeting of diseased tissue to monitor and control treatment during surgical and interventional procedures. He pioneered the field of Magnetic Resonance Imaging-guided interventions and introduced of a variety of new medical procedures based on novel combinations of imaging and therapy delivery.
Nina Starr Braunwald was an American thoracic surgeon and medical researcher who was among the first women to perform open-heart surgery. She was also the first woman to be certified by the American Board of Thoracic Surgery,and the first to be elected to the American Association for Thoracic Surgery. In 1960,at the age of 32,she led the operative team at the U.S. National Institutes of Health (NIH) that implanted the first successful artificial mitral human heart valve replacement,which she had designed and fabricated.
Howard L. Weiner is an American neurologist,neuroscientist and immunologist who is also a writer and filmmaker. He performs clinical and basic research focused on multiple sclerosis (MS) and other neurologic diseases such as Alzheimer's disease and Lou Gehrig's disease (ALS). His work also focuses on autoimmune diseases such as diabetes. Weiner is the Robert L. Kroc Professor of Neurology at Harvard Medical School,director of the Brigham MS Center at the Brigham and Women's Hospital and co-director of the Ann Romney Center for Neurologic Diseases established in 2014,at the Brigham and Women's Hospital in Boston,Massachusetts.
David M. Eisenberg is an American physician,alternative medicine researcher,and the Bernard Osher Distinguished Associate Professor of Medicine at Harvard Medical School. He is also the founder of the Osher Center for Complementary and Integrative Medical Therapies,a healthcare clinic associated with Brigham and Women's Hospital,and served as its director from 2000 to 2010. He is also the founder of the "Healthy Kitchens/Healthy Lives" initiative,which,according to the New York Times,aims "to tear down the firewall between “healthy”and “crave-able”cuisine."
Simin Liu is an American physician-scientist and epidemiologist. He is recognized internationally for his leadership in the research of nutrition,genetics,epidemiology,and the environmental and biological determinants of complex diseases,particularly those related to cardiometabolic health in diverse populations. His research has pioneered novel concepts,uncovered critical mechanisms and risk factors,and developed research frameworks for diabetes and cardiovascular diseases. A hallmark of Liu's work is when his lab was among the first to define and quantify dietary glycemic load in humans,providing key insights into the functional role of dietary carbohydrates in the development of health outcomes. This novel nutritional concept has since become a cornerstone of clinical diabetes management,nutritional epidemiology,and dietary feeding trials in diverse populations worldwide.
Jeffrey D. Macklis is an American neuroscientist. He is the Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology and Center for Brain Science at Harvard University,Professor of Neurology [Neuroscience] at Harvard Medical School,and on the Executive Committee and a Member of the Principal Faculty of the Neuroscience / Nervous System Diseases Program at the Harvard Stem Cell Institute.
Vijay K. Kuchroo is an Indian-American immunologist and serial entrepreneur. He is the Samuel L. Wasserstrom chair of Neurology at Harvard Medical School,and Brigham and Women's Hospital. He is also the director of the Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women's Hospital in Boston,Massachusetts.
Monica Bertagnolli is an American surgical oncologist and the 17th director of the National Institutes of Health. She previously served as the 16th director of the National Cancer Institute (NCI). Prior to her governmental positions,she worked at Brigham and Women's Hospital and Dana–Farber Cancer Institute and was the Richard E. Wilson Professor of Surgery at Harvard Medical School.
Kathryn T. Hall is a leader in placebo research,Assistant professor of medicine part-time and molecular biologist who directs research or teaches at several institutions,including the following: